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DISEASE RISK
Mapping the emerging burden
of dengue
The first nationally-representative survey of dengue has revealed the
growing burden of the disease in Bangladesh.
OLIVER BRADY
D
engue is a viral disease spread by mos-
quitoes and found in more than 120
countries around the world
(Bhatt et al., 2013). Because the species that
transmits the disease, Aedes aegypti, lives in
dense man-made environments, recent urbaniza-
tion throughout the tropical world has acceler-
ated the spread of dengue (Bhatt et al., 2013).
Aedes aegypti is also the primary vector for a
number of other diseases, including Zika, chikun-
gunya and Yellow Fever, so understanding how
to control the global emergence of dengue
could help to prevent the spread of these
diseases.
However, getting accurate data on who is
being infected is surprisingly difficult. Only a
small proportion of people (11–32%) are likely to
have symptoms after contracting dengue, with
few being sick enough to require formal medical
care (Bhatt et al., 2013; Undurraga et al.,
2013). And even if they receive medical care,
misdiagnosis and under-reporting are common.
This means that maps based on clinical case
counts are not always useful, and may just reflect
differences in access to healthcare, diagnostics
and ability to report cases.
The gold standard for measuring who has
been infected with dengue is a seroprevalence
survey, where serum (blood) samples are taken
from a representative group of people and
tested for antibodies against the dengue virus.
Now, in eLife, Henrik Salje and colleagues (who
are based at institutes in France, the United
States and Bangladesh) report how they have
used this approach, which is usually reserved for
local studies, on a scale never seen before to
provide new insights into the transmission of
dengue at a national level in Bangladesh
(Salje et al., 2019).
Salje et al. visited 70 randomly selected com-
munities across Bangladesh, between 2014 and
2016. During these visits, randomly selected resi-
dents were asked to contribute a blood sample
and to answer a range of questions about
behaviours thought to increase or decrease the
risk of dengue. Overall, they found that 24% of
participants showed evidence of previous den-
gue infection: this was much lower than the fig-
ures in other affected regions, such as Indonesia
(~70%), where dengue has been around much
longer (Tam et al., 2018). They also found that
males were more likely to be infected than
females, and that regular travellers were almost
twice as likely to be infected as people who did
not travel regularly.
However, the biggest factor in determining
the risk of infection was location: over 80% of
individuals in big cities, such as Dhaka, had been
infected with the virus at some stage in their life,
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whereas fewer than 5% of people in rural areas
showed signs of any previous infection. Using
the results of their survey, Salje et al. were able
to construct models that could predict seroprev-
alence in areas where data had not been col-
lected, and then use this information to produce
an updated risk map for dengue across Bangla-
desh (Figure 1).
By comparing seroprevalence between differ-
ent age groups, Salje et al. were able to esti-
mate the rate at which infections accumulate.
Using standard ’catalytic models’ (and making
some assumptions about how long dengue has
been in Bangladesh) they estimated that about
2.4 million people, out of a population of ~160
million, are infected with dengue virus in Bangla-
desh each year. In contrast fewer than 6,000
dengue cases per year were reported over the
same time period, mostly in Dhaka
(Mutsuddy et al., 2019). The results from this
survey have the potential to play an important
role in expanding and adapting dengue surveil-
lance practices in Bangladesh.
Salje et al. also suggest that the current distri-
bution of mosquito species in Bangladesh may
be the cause of the limited spread of dengue.
The mosquito that carries dengue, Aedes
aegypti, was found in higher abundance in urban
areas, whilst Aedes albopictus, a mosquito spe-
cies that carries and transmits the virus less
effectively, was more common in rural areas.
Together, these results paint a picture of a
country part way through the emergence of den-
gue. Transmission is already high in urban
centres but – unlike many countries in South
East Asia and Latin America – regular, continu-
ous transmission has yet to spread to more rural
areas. However, more work is needed to under-
stand how human movement and lower trans-
mission potential in rural areas interact in
shaping the current distribution of dengue in
Bangladesh (Wesolowski et al., 2015). Genetic
analyses of circulating dengue viruses can be
used to identify the origins of outbreaks
(Salje et al., 2017), which could help with efforts
to contain the spread of the virus.
Figure 1. Mapping dengue risk in Bangladesh. A cross-sectional seroprevalence map (right) of dengue risk in
Bangladesh, based on data collected from 70 communities throughout the country (Salje et al., 2019), shows that
the risk is highest in the cities of Chittagong (in the south east), Khulna (south west) and Dhaka (in the middle of
the country). Previous maps, such as this map based on data from Bhatt et al. (2013) (left), have predicted more
widespread risk throughout the country, but these maps were largely based on less detailed data and often relied
on extrapolation from nearby countries. This new study by Sajle et al. may suggest that there are unique, as yet
unknown, factors that constrain the current distribution of dengue in Bangladesh.
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By proving the feasibility and value of nation-
ally-representative seroprevalence surveys for
dengue, it is hoped that the results of Salje et al.
will renew interest in mass disease surveillance
for dengue. Such community-representative sur-
veys have proven instrumental for targeting and
evaluating interventions for successful malaria
control (Bhatt et al., 2015). A range of new den-
gue vaccines are currently becoming available,
but some of these will only be beneficial if tar-
geted to the areas of highest transmission
(Flasche et al., 2016). Therefore, having regu-
larly updated maps that accurately show the
national spread of dengue will be critical in the
ongoing fight against further expansion of the
disease.
Oliver Brady is in the Department of Infectious
Disease Epidemiology, London School of Hygiene &
Tropical Medicine, London, United Kingdom
oliver.brady@lshtm.ac.uk
http://orcid.org/0000-0002-3235-2129
Competing interests: The author declares that no
competing interests exist.
Published 13 May 2019
References
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow
AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG,
Sankoh O, Myers MF, George DB, Jaenisch T, Wint
GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. 2013.
The global distribution and burden of dengue. Nature
496:504–507. DOI: https://doi.org/10.1038/
nature12060, PMID: 23563266
Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B,
Dalrymple U, Battle K, Moyes CL, Henry A, Eckhoff PA,
Wenger EA, Brie¨t O, Penny MA, Smith TA, Bennett A,
Yukich J, Eisele TP, Griffin JT, Fergus CA, Lynch M,
et al. 2015. The effect of malaria control on
Plasmodium falciparum in Africa between 2000 and
2015. Nature 526:207–211. DOI: https://doi.org/10.
1038/nature15535, PMID: 26375008
Flasche S, Jit M, Rodrı´guez-Barraquer I, Coudeville L,
Recker M, Koelle K, Milne G, Hladish TJ, Perkins TA,
Cummings DA, Dorigatti I, Laydon DJ, Espan˜a G,
Kelso J, Longini I, Lourenco J, Pearson CA, Reiner RC,
Mier-Y-Tera´n-Romero L, Vannice K, et al. 2016. The
Long-Term safety, public health impact, and Cost-
Effectiveness of routine vaccination with a
recombinant, Live-Attenuated dengue vaccine
(Dengvaxia): A model comparison study. PLOS
Medicine 13:e1002181. DOI: https://doi.org/10.1371/
journal.pmed.1002181, PMID: 27898668
Mutsuddy P, Tahmina Jhora S, Shamsuzzaman AKM,
Kaisar SMG, Khan MNA. 2019. Dengue situation in
Bangladesh: An epidemiological shift in terms of
morbidity and mortality. Canadian Journal of Infectious
Diseases and Medical Microbiology 2019:1–12.
DOI: https://doi.org/10.1155/2019/3516284
Salje H, Lessler J, Maljkovic Berry I, Melendrez MC,
Endy T, Kalayanarooj S, A-Nuegoonpipat A, Chanama
S, Sangkijporn S, Klungthong C, Thaisomboonsuk B,
Nisalak A, Gibbons RV, Iamsirithaworn S, Macareo LR,
Yoon IK, Sangarsang A, Jarman RG, Cummings DA.
2017. Dengue diversity across spatial and temporal
scales: Local structure and the effect of host
population size. Science 355:1302–1306. DOI: https://
doi.org/10.1126/science.aaj9384, PMID: 28336667
Salje H, Paul KK, Paul R, Rodriguez-Barraquer I,
Rahman Z, Alam MS, Rahman M, Al-Amin HM,
Heffelfinger J, Gurley E. 2019. Nationally-
representative serostudy of dengue in Bangladesh
allows generalizable disease burden estimates. eLife 8:
e42869. DOI: https://doi.org/10.7554/eLife.42869,
PMID: 30958263
Tam CC, O’Driscoll M, Taurel AF, Nealon J,
Hadinegoro SR. 2018. Geographic variation in dengue
seroprevalence and force of infection in the urban
paediatric population of Indonesia. PLOS Neglected
Tropical Diseases 12:e0006932. DOI: https://doi.org/
10.1371/journal.pntd.0006932, PMID: 30388105
Undurraga EA, Halasa YA, Shepard DS. 2013. Use of
expansion factors to estimate the burden of dengue in
Southeast Asia: A systematic analysis. PLOS Neglected
Tropical Diseases 7:e2056. DOI: https://doi.org/10.
1371/journal.pntd.0002056, PMID: 23437407
Wesolowski A, Qureshi T, Boni MF, Sundsøy PR,
Johansson MA, Rasheed SB, Engø-Monsen K, Buckee
CO. 2015. Impact of human mobility on the
emergence of dengue epidemics in Pakistan. PNAS
112:11887–11892. DOI: https://doi.org/10.1073/pnas.
1504964112, PMID: 26351662
Brady. eLife 2019;8:e47458. DOI: https://doi.org/10.7554/eLife.47458 3 of 3
Insight Disease Risk Mapping the emerging burden of dengue
